The prevalence of oesophageal eosinophilia and eosinophilic oesophagitis: a prospective study in unselected patients presenting to endoscopy
Article first published online: 26 FEB 2013
© 2013 Blackwell Publishing Ltd
Alimentary Pharmacology & Therapeutics
Volume 37, Issue 8, pages 825–832, April 2013
How to Cite
Aliment Pharmacol Ther 2013; 37: 825–832
- Issue published online: 18 MAR 2013
- Article first published online: 26 FEB 2013
- Manuscript Accepted: 6 FEB 2013
- Manuscript Revised: 5 FEB 2013
- Manuscript Revised: 9 OCT 2012
- Manuscript Received: 19 SEP 2012
- National Institutes of Health. Grant Number: NCI R01 116845
- Houston VA HSR&D Center of Excellence. Grant Number: HFP90-020
- Texas Digestive Disease Center. Grant Number: DK58338
- NIDDK. Grant Number: K24-04-107
Table S1. Demographic and clinical features of the overall study population categorized based on the presence or absence of oesophageal eosinophilia, defined as >15 eosinophils high-power field in oesophageal biopsies.
Table S2. Demographic and clinical features of those undergoing non-urgent EGD (endoscopy group only) categorized based on the presence or absence of oesophageal eosinophilia, defined as ≥15 eosinophils per high-power field in oesophageal biopsies.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.